Autism, epilepsy and tuberous sclerosis complex: a functional model linked to mTOR pathway
JJ Garc�a-Pe�as, I Carreras-S��ez�- Revista de Neurologia, 2013 - europepmc.org
JJ Garc�a-Pe�as, I Carreras-S��ez
Revista de Neurologia, 2013•europepmc.orgConclusions A greater understanding of the pathogenetic mechanisms underlying autism in
TSC could help in devising targeted and potentially more effective treatment strategies.
Antagonism of the mTOR pathway with rapamycin and everolimus may provide new
therapeutic options for these TSC patients.
TSC could help in devising targeted and potentially more effective treatment strategies.
Antagonism of the mTOR pathway with rapamycin and everolimus may provide new
therapeutic options for these TSC patients.
Conclusions
A greater understanding of the pathogenetic mechanisms underlying autism in TSC could help in devising targeted and potentially more effective treatment strategies. Antagonism of the mTOR pathway with rapamycin and everolimus may provide new therapeutic options for these TSC patients.
europepmc.org